Two refractive EDOF IOLs compared within the same patient
In a randomized masked study, 40 patients received DEN00V in one eye and AN6V in the fellow eye. Both provided extended vision at three months, while the primary endpoint favored AN6V.
doi: 10.1016/j.ajo.2026.04.014